UB Paderborn / Katalog / Suche / in CDI

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

Leukemia, 2014-04, Vol.28 (4), p.970-973

2014

Volltextzugriff (PDF)

Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1224-1229

2013

Volltextzugriff (PDF)

Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation

Transplant infectious disease, 2013-10, Vol.15 (5), p.533-539

2013

Volltextzugriff (PDF)

Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (9), p.821-826

2008

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

Bone marrow transplantation (Basingstoke), 2012-09, Vol.47 (9), p.1171-1177

2012

Volltextzugriff (PDF)

Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells

Cancer gene therapy, 2014-07, Vol.21 (7), p.275-282

2014

Volltextzugriff (PDF)

Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors

Bone marrow transplantation (Basingstoke), 2016-03, Vol.51 (3), p.428-431

2016

Volltextzugriff (PDF)

Hämatopoetische Stammzelltransplantation

Onkologie (Heidelberg, Germany), 2009-06, Vol.15 (6), p.564-574

2009

Volltextzugriff (PDF)

Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells

Cancer gene therapy, 2013-07, Vol.20 (7), p.421-427

2013

Volltextzugriff (PDF)

Increased susceptibility for aspergillosis and post‐transplant immune deficiency in patients with gene variants of TLR 4 after stem cell transplantation

Transplant infectious disease, 2013-10, Vol.15 (5), p.533-539

2013

Volltextzugriff (PDF)

Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD

Bone marrow transplantation (Basingstoke), 2014-06, Vol.49 (6), p.800-805

2014

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.654-662

2016

Volltextzugriff (PDF)

Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9

Bone marrow transplantation (Basingstoke), 2009-09, Vol.44 (5), p.295-302

2009

Volltextzugriff (PDF)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (12), p.1089-1095

2003

Volltextzugriff (PDF)

Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.732-733

2013

Volltextzugriff (PDF)

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation

Blood, 1999-07, Vol.94 (2), p.455-464

1999

Volltextzugriff (PDF)

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

Leukemia, 2002-12, Vol.16 (12), p.2423-2428

2002

Volltextzugriff (PDF)

Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT

Bone marrow transplantation (Basingstoke), 2009-08, Vol.44 (4), p.265-266

2009

Volltextzugriff (PDF)

Early Cytomegalovirus Replication After Allogeneic Stem Cell Transplantation Is Associated With a Dramatically Reduced Relapse Risk in Acute Myeloid Leukemia Patients: Evidence for a Putative Virus-Versus-Leukemia Effect

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S161-S161

2011

Volltextzugriff (PDF)

Bone Marrow or Peripheral Blood Stem Cell Transplantation From Unrelated Donors in Adult Patients With Acute Myeloid Leukemia

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, Vol.17 (2), p.S287-S287

2011

Volltextzugriff (PDF)

Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2007-10, Vol.40 (8), p.659

2007

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial

Blood, 2007-11, Vol.110 (11), p.328-328

2007

Volltextzugriff (PDF)

Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantation

International journal of clinical pharmacology and therapeutics, 2004-11, Vol.42 (11), p.654

2004

Volltextzugriff (PDF)

Hämatopoetische Stammzelltransplantation: Indikationen, Ergebnisse und Entwicklungsperspektiven

Der Onkologe, 2009-06, Vol.15 (6), p.564-574

2009

Volltextzugriff (PDF)

Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation

Transplant infectious disease, 2005-09, Vol.7 (3-4), p.137-145

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?

Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation

Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning

Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells

Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors

Hämatopoetische Stammzelltransplantation

Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells

Increased susceptibility for aspergillosis and post‐transplant immune deficiency in patients with gene variants of TLR 4 after stem cell transplantation

Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor

Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantation

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT

Early Cytomegalovirus Replication After Allogeneic Stem Cell Transplantation Is Associated With a Dramatically Reduced Relapse Risk in Acute Myeloid Leukemia Patients: Evidence for a Putative Virus-Versus-Leukemia Effect

Bone Marrow or Peripheral Blood Stem Cell Transplantation From Unrelated Donors in Adult Patients With Acute Myeloid Leukemia

Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial

Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantation

Hämatopoetische Stammzelltransplantation: Indikationen, Ergebnisse und Entwicklungsperspektiven

Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation

Suchergebnisse filtern